Key research themes
1. How does Beclin-1 function as a central regulator of autophagy and membrane trafficking in cellular physiology and disease contexts?
This research area investigates Beclin-1 orthologs as key integrative hubs coordinating autophagy initiation and other membrane trafficking pathways such as endocytosis and phagosomal maturation. Studies elucidate the molecular composition and regulation of Beclin-1-associated PI3KC3 complexes, their cross-talk with signaling pathways (oncogenic, immune, stress-responsive), and how these functions underpin physiological processes including tumor suppression, metabolism, immunity, and tissue homeostasis. Understanding these mechanisms can inform therapeutic targeting and modulation of autophagy in various clinical diseases.
2. What is the role of Beclin-1-mediated autophagy regulation in cancer progression and growth factor receptor signaling?
This research theme addresses Beclin-1’s function as a haploinsufficient tumor suppressor traditionally linked to autophagy but now recognized for autophagy-independent roles in modulating growth factor receptor endocytic trafficking and signaling pathways such as AKT and ERK. Studies explore the molecular mechanisms by which Beclin-1 regulates early endosome maturation and how its loss sustains oncogenic signaling, thereby influencing tumor development and therapeutic responses.
3. How does Beclin-1 and related autophagy proteins modulate inflammatory and immune-mediated diseases including autoimmune disorders and vascular inflammation?
This theme investigates Beclin-1’s impact on inflammatory disease pathogenesis via autophagic regulation of immune signaling pathways. Research focuses on gene expression patterns involving Beclin-1 in autoimmune diseases such as rheumatoid arthritis and Behçet’s syndrome, elucidates how Beclin orthologs influence cytokine production and inflammasome activation, and assesses implications for vascular inflammation and tissue homeostasis. These insights have therapeutic potential for targeting autophagy in chronic inflammatory conditions.